AXA Balance Sheet Health

Financial Health criteria checks 3/6

AXA has a total shareholder equity of €59.0B and total debt of €60.8B, which brings its debt-to-equity ratio to 103%. Its total assets and total liabilities are €638.9B and €579.9B respectively. AXA's EBIT is €10.0B making its interest coverage ratio 16.7. It has cash and short-term investments of €74.3B.

Key information

103.0%

Debt to equity ratio

€60.78b

Debt

Interest coverage ratio16.7x
Cash€74.33b
Equity€59.02b
Total liabilities€579.92b
Total assets€638.93b

Recent financial health updates

No updates

Recent updates

If EPS Growth Is Important To You, AXA (EPA:CS) Presents An Opportunity

Dec 10
If EPS Growth Is Important To You, AXA (EPA:CS) Presents An Opportunity

AXA SA's (EPA:CS) Low P/E No Reason For Excitement

Nov 19
AXA SA's (EPA:CS) Low P/E No Reason For Excitement

With EPS Growth And More, AXA (EPA:CS) Makes An Interesting Case

Aug 26
With EPS Growth And More, AXA (EPA:CS) Makes An Interesting Case

AXA SA's (EPA:CS) Low P/E No Reason For Excitement

Jul 23
AXA SA's (EPA:CS) Low P/E No Reason For Excitement

If EPS Growth Is Important To You, AXA (EPA:CS) Presents An Opportunity

May 21
If EPS Growth Is Important To You, AXA (EPA:CS) Presents An Opportunity

Increases to CEO Compensation Might Be Put On Hold For Now at AXA SA (EPA:CS)

Apr 17
Increases to CEO Compensation Might Be Put On Hold For Now at AXA SA (EPA:CS)

Analysts Just Made A Major Revision To Their AXA SA (EPA:CS) Revenue Forecasts

Mar 01
Analysts Just Made A Major Revision To Their AXA SA (EPA:CS) Revenue Forecasts

Financial Position Analysis

Short Term Liabilities: CS's short term assets (€121.9B) exceed its short term liabilities (€15.5B).

Long Term Liabilities: CS's short term assets (€121.9B) do not cover its long term liabilities (€564.4B).


Debt to Equity History and Analysis

Debt Level: CS has more cash than its total debt.

Reducing Debt: CS's debt to equity ratio has increased from 62.9% to 103% over the past 5 years.

Debt Coverage: CS's debt is not well covered by operating cash flow (14.2%).

Interest Coverage: CS's interest payments on its debt are well covered by EBIT (16.7x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 09:46
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AXA SA is covered by 47 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bassem NeiferAlphaValue
Markus MayerBaader Helvea Equity Research
null nullBanco de Sabadell. S.A.